Clinical Trial: Differential Molecular Mechanisms Underlying Early Phenotypic Remodeling Driven by Genetic Heterogeneity in Hypertrophic Cardiomyopathy (China)

Posted On: 2026-11-02

China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Differential Molecular Mechanisms Underlying Early Phenotypic Remodeling Driven by Genetic Heterogeneity in Hypertrophic Cardiomyopathy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135677

Registration Time: 2026/11/01

Type: Observational study

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349853

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Differential Molecular Mechanisms Underlying Early Phenotypic Remodeling Driven by Genetic Heterogeneity in Hypertrophic Cardiomyopathy (China)